Insulin receptor substrate proteins and diabetes

Archives of Pharmacal Research

Volumn 27, Issue 4, 2004, Pages 361-370

  Yong, Hee Lee ^a   White, Morris F ^b,c  

^a Chungbuk National University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cytolcine; Diabetes; Hyperinculinemia; Insulin receptor substrate (IRS); Insulin resiztance; Insulin like growth factor (IGF); Intracelluar signalling cascaldes; Pancreatic cell

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE 2 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-2 PROTEIN; PHOSPHOPROTEIN; SIGNAL PEPTIDE;

ANIMAL; DIABETES MELLITUS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; DIABETES MELLITUS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PHOSPHOPROTEINS; RECEPTOR, INSULIN;

EID: 12344322710     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/bf02980074     Document Type: Article

References (85)

1. Abe, H., Yamada, N., Kamata, K., Kuwaki, T., Shimada, M., Osuga, J., Shionoiri, F., Yahagi, N., Kadowaki, T., Tamemoto, H., Ishibashi, S., Yazaki, Y., and Makuuchi, M., Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin. Invest., 101, 1784-1788 (1998).
2. 2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307. J. Biol. Chem., 275, 9047-9054 (2000).
3. Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., and White, M. F., Phosphorylation of ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem., 277, 1531-1537 (2002).
4. Alessi, D. R. and Cohen, P., Mechanism of activation and function of protein kinase B. Curr. Opin. Genet. Dev., 8, 55-62 (1998).
5. Araki, E., Lipes, M. A., Patti, M. E., Bruning, J. C., Haag, B., III, Johnson, R. S., and Kahn, C. R., Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature, 372, 186-190 (1994).
6. 2+ stores in insulin-stimulated insulin secretion in β-cells. J. Biol. Chem., (2000).
7. Backer, J. M., Myers, M. G., Jr., Shoelson, S. E., Chin, D. J., Sun, X. J., Miralpeix, M., Hu, P., Margolis, B., Skolnik, E. Y., Schlessinger, J., and White, M. F., Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J., 11, 3469-3479 (1992).
8. Baker, J., Liu, J. P., Robertson, E. J., and Efstratiadis, A., Role of insulin-like growth factors in embryonic and postnatal growth. Cell, 75, 73-82 (1993).
9. Baron, S. H., Salicylates as hypoglycemic agents. Diabetes Care, 5, 64-71 (1982).
10. Baud, V. and Karin, M., Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol., 11, 372-377 (2001).
11. Baumann, C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., Bickel, P. E., Pessin, J. E., and Saltiel, A. R., CAP defines a second signalling pathway required for insulin-stimulated glucose transport [see comments]. Nature, 407, 202-207 (2000).
12. Bjornholm, M., He, A. R., Attersand, A., Lake, S., Liu, S. C., Lienhard, G. E., Taylor, S., Arner, P., and Zierath, J. R., Absence of functional insulin receptor substrate-3 (IRS-3) gene in humans. Diabetologia, 45, 1697-1702 (2002).
13. Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E., Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell, 96, 857-868 (1999).
14. Bruning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Horsch, D., Accili, D., Goodyear, L. J., and Kahn, C. R., A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell, 2, 559-569 (1998).
15. Burghes, A. H., Vaessin, H. E. and de La, C. A., Genetics. The land between Mendelian and multifactorial inheritance. Science, 293, 2213-2214 (2001).
16. Burks, D. J., de Mora, J. F., Schubert, M., Withers, D. J., Myers, M. G., Towery, H. H., Altamuro, S. L., Flint, C. L., and White, M. F., IRS-2 pathways integrate female reproduction and energy homeostasis. Nature, 407, 377-382 (2000).
17. Burks, D. J., Pons, S., Towery, H., Smith-Hall, J., Myers, M. G., Jr., Yenush, L., and White, M. F., Heterologous PH domains do not mediate coupling of IRS-1 to the insulin receptor. J. Biol. Chem., 272, 27716-27721 (1997).
18. Burks, D. J., Wang, J., Towery, H., Ishibashi, O., Lowe, D., Riedel, H., and White, M. F., IRS pleckstrin homology domains bind to acidic motifs in proteins. J. Biol. Chem., 273, 31061-31067 (1998).
19. Cai, D., Dhe-Paganon, S., Melendez, P. A., Lee, J., and Shoelson, S. E., Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/DOK5. J. Biol. Chem., 278, 25323-25330 (2003).
20. Chiang, S. H., Baumann, C. A., Kanzaki, M., Thurmond, D. C., Watson, R. T., Neudauer, C. L., Macara, I. G., Pessin, J. E., and Saltiel, A. R., Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature, 410, 944-948 (2001).
21. 13C-nuclear magnetic resonance spectroscopy studies of hepatic glucose metabolism in normal subjects and subjects with insulin-dependent diabetes mellitus. J. Clin. Invest., 94, 2369-2376 (1994).
22. DeFronzo, R. A., Pathogenesis of type 2 diabetes: Metabolic and molecular implications for identifying diabetes genes. Diabetes Rev., 5, 177-269 (1997).
23. DeFronzo, R. A. and Ferrannini, E., Regulation of intermediary metabolism during fasting and feeding, In DeGroot, L.J. and Jameson, J.L. (Eds.). Endocrinology. W.B. Saunders Co., Philadelphia, pp. 737-755, (2001).
24. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E., Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science, 275, 661-665 (1997).
25. Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J.-H., Masiar, F., Kan, Y. W., Goldfine, I. D., Roth, R. A., and Rutter, W. J., The human insulin receptor cDNA: The structural basis for hormone activated transmembrane signalling. Cell, 40, 747-758 (1985).
26. Farhang-Fallah, J., Yin, X., Trentin, G., Cheng, A. M., and Rozakis-Adcock, M., Cloning and characterization of PHIP, a novel insulin receptor substrate-1 pleckstrin homology domain interacting protein. J. Biol. Chem., 275, 40492-40497 (2000).
27. Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., and Vigneri, R., Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol. Cell Biol., 19, 3278-3288 (1999).
28. Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R., Yen, F. T., Bihain, B. E., and Lodish, H. F., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A., 98, 2005-2010 (2001).
29. Hellstrom, A., Perruzzi, C., Ju, M., Engstrom, E., Hard, A. L., Liu, J. L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Sjodell, L., LeRoith, D., Senger, D. R., and Smith, L. E., Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. U.S.A., 98, 5804-5808 (2001).
30. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z., Uysal, K. T., Maeda, K., Karin, M., and Hotamisligil, G. S., A central role for JNK in obesity and insulin resistance. Nature, 420, 333-336 (2002).
31. Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E., Bosque-Plata, L., Horikawa, Y., Oda, Y., Yoshiuchi, I., Colilla, S., Polonsky, K. S., Wei, S., Concannon, P., Iwasaki, N., Schulze, J., Baier, L. J., Bogardus, C., Groop, L., Boerwinkle, E., Hanis, C. L., and Bell, G. I., Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet., 26, 163-175 (2000).
32. Hotamisligil, G. S., Peraldi, P., Budvari, A., Ellis, R. W., White, M. F., and Spiegelman, B. M., IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α-and obesity-induced insulin resistance. Science, 271, 665-668 (1996).
33. Hotamisligil, G. S. and Spiegelman, B. M., Adipose expression of TNFα:Direct Role in Obesity-linked insulin resistance. Science, 259, 87-91 (1999).
34. Kadowaki, T., Tamemoto, H., Tobe, K., Terauchi, Y., Ueki, K., Kaburagi, Y., Yamauchi, T., Satoh, S., Sekihara, H., Aizawa, S., and Yazaki, Y., Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 and identification of insulin receptor substrate-2. Diabet. Med., 13, S103-S108 (1996).
35. Kahn, B. B. and Flier, J. S., Obesity and insulin resistance. J. Clin. Invest., 106, 473-481 (2000).
36. Kim, J. K., Kim, Y. J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., Shoelson, S. E., and Shulman, G. I., Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest., 108, 437-446 (2001).
37. Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W. H., III, Wright, C. V., White, M. F., Arden, K. C., and Accili, D., The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Invest., 110, 1839-1847 (2002).
38. Kops, G. J. and Burgering, B. M., Forkhead transcription factors are targets of signalling by the proto- oncogene PKB (C-AKT). J. Anat., 197 Pt 4, 571-574 (2000).
39. Kotani, K., Wilden, P., and Pillay, T. S., SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem. J., 335, 103-109 (1998).
40. Kuan, C. Y., Yang, D. D., Samanta Roy, D. R., Davis, R. J., Rakic, P., and Flavell, R. A., The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron, 22, 667-676 (1999).
41. Kulkarni, R. N., Bruning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., and Kahn, C. R., Tissue-specific knockout of the insulin receptor in pancreatic b cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell, 96, 329-339 (1999).
42. Kushner, J. A., Ye, J., Schubert, M., Burks, D. J., Dow, M. A., Flint, C. L., Dutta, S., Wright, C. V., Montminy, M. R., and White, M. F., Pdx1 restores beta cell function in Irs2 knockout mice. J. Clin. Invest., 109, 1193-1201 (2002).
43. Lavan, B. E., Lane, W. S., and Lienhard, G. E., The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem., 272, 11439-11443 (1997).
44. Lee, Y. H., Giraud, J., Davis, R. J., and White, M. F., c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem., 278, 2896-2902 (2003).
45. Liu, J. P., Baker, J., Perkins, J. A., Robertson, E. J., and Efstratiadis, A., Mice carrying null mutations of the genes encoding insulin-like growth factor I (lgf-1) and type 1 IGF receptor (lgf1r). Cell, 75, 59-72 (1993).
46. Lock, P., Casagranda, F., and Dunn, A. R., Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck. J. Biol. Chem., 274, 22775-22784 (1999).
47. Lupu, F., Terwilliger, J. D., Lee, K., Segre, G. V., and Efstratiadis, A., Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol., 229, 141-162 (2001).
48. Merforth, S., Osmers, A., and Dahlmann, B., Alterations of proteasome activities in skeletal muscle tissue of diabetic rats. Mol. Biol. Rep., 26, 83-87 (1999).
49. Mitch, W. E., Bailey, J. L., Wang, X., Jurkovitz, C., Newby, D., and Price, S. R., Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol, 276, C1132-C1138 (1999).
50. Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., III, Arden, K. C., and Accili, D., The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell, 4, 119-129 (2003).
51. Noguchi, T., Matozaki, T., Inagaki, K., Tsuda, M., Fukunaga, K., Kitamura, Y., Kitamura, T., Shii, K., Yamanashi, Y., and Kasuga, M., Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J., 18, 1748-1760 (1999).
52. O'Brien, R. M., Streeper, R. S., Ayala, J. E., Stadelmaier, B. T., and Hornbuckle, L. A., Insulin-regulated gene expression. Biochem. Soc. Trans., 29, 552-558 (2001).
53. Patti, M. E., Sun, X. J., Bruning, J. C., Araki, E., Lipes, M. A., White, M. F., and Kahn, C. R., 4PS/IRS-2 is the alternative substrate of the insulin receptor in IRS-1 deficient mice. J. Biol. Chem., 270, 24670-24673 (1995).
54. Pawson, T. and Scott, J. D., Signaling through scaffold, anchoring, and adaptor proteins. Science, 278, 2075-2080 (1997).
55. Peraldi, P., Hotamisligil, G. S., Buurman, W. A., White, M. F., and Spiegelman, B. M., Tumor necrosis factor (TNF)-α inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem., 271, 13018-13022 (1996).
56. Pessin, J. E. and Saltiel, A. R., Signaling pathways in insulin action: molecular targets of insulin resistance. J. Clin. Invest., 106, 165-169 (2000).
57. Pete, G., Fuller, C. R., Oldham, J. M., Smith, D. R., D'Ercole, A. J., Kahn, C. R., and Lund, P. K., Postnatal growth responses to insulin-like growth factor I in insulin receptor substrate-1-deficient mice. Endocrinology, 140, 5478-5487 (1999).
58. Previs, S. F., Withers, D. J., Ren, J. M., White, M. F., and Shulman, G. I., Contrasting effects of IRS-1 vs IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J. Biol. Chem., 275, 38990-38994 (2000).
59. Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., and Spiegelman, B. M., Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature, (2003).
60. Reaven, G. M., Banting lecture: Role of insulin resistance in human disease. Diabetes, 37, 1595-1607 (1988).
61. Rincon, M., Whitmarsh, A., Yang, D. D., Weiss, L., Derijard, B., Jayaraj, P., Davis, R. J., and Flavell, R. A., The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes. J. Exp. Med., 188, 1817-1830 (1998).
62. Rohl, M., Pasparakis, M., Baudler, S., Baumgartl, J., Gautam, D., Huth, M., De Lorenzi, R., Krone, W., Rajewsky, K. and Bruning, J. C., Conditional disruption of IκB kinase 2 fails to prevent obesity-induced insulin resistance. J. Clin. Invest., 113, 474-481 (2004).
63. Rui, L., Fisher, T. L., Thomas, J., and White, M. F., Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. J. Biol. Chem., 276, 40362-40367 (2001).
64. Saltiel, A. R., New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell, 104, 517-529 (2001).
65. Savkur, R. S., Philips, A. V. and Cooper, T. A., Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 29, 40-47 (2001).
66. Schubert, M., Brazil, D. P., Burks, D. J., Kushner, J. A., Ye, J., Flint, C. L., Farhang-Fallah, J., Dikkes, P., Warot, X. M., Rio, C., Corfas, G., and White, M. F., Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J. Neurosci., 23, 7084-7092 (2003).
67. Shulman, G. I., Cellular mechanisms of insulin resistance. J. Clin. Invest., 106, 171-176 (2000).
68. Sreenan, S. K., Zhou, Y. P., Otani, K., Hansen, P. A., Currie, K. P., Pan, C. Y., Lee, J. P., Ostrega, D. M., Pugh, W., Horikawa, Y., Cox, N. J., Hanis, C. L., Burant, C. F., Fox, A. P., Bell, G. I., and Polonsky, K. S., Calpains play a role in insulin secretion and action. Diabetes, 50, 2013-2020 (2001).
69. Sun, X. J., Goldberg, J. L., Qiao, L. Y., and Mitchell, J. J., Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. Diabetes, 48, 1359-1364 (1999).
70. Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., Sekihara, H., Yoshioka, S., Horikoshi, H., Furuta, Y., Ikawa, Y., Kasuga, M., Yazaki, Y., and Aizawa, S., Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature, 372, 182-186 (1994).
71. Thomas, M. K., Devon, O. N., Lee, J. H., Peter, A., Schlosser, D. A., Tenser, M. S., and Habener, J. F., Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J. Clin. Invest., 108, 319-329 (2001).
72. Uchida, T., Myers, M. G., Jr., and White, M. F., IRS-4 mediates activation of PKB/Akt during insulin stimulation without inhibition of apoptosis. Mol. Cell Biol., 20, 126-138 (2000).
73. Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M., Mason, A., Seeburg, P. H., Grunfeld, C., Rosen, O. M., and Ramachandran, J., Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature, 313, 756-761 (1985).
74. Uysal, K. T., Wiesbrock, S. M., and Hotamisligil, G. S., Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistane in genetic obesity. Endocrinology, 139, 4832-4838 (1998).
75. Uysal, K. T., Wiesbrock, S. M., Marino, M. W., and Hotamisligil, G. S., Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature, 389, 610-614 (1997).
76. White, M. F., Insulin signaling in health and disease. Science, 302, 1710-1711 (2003).
77. White, M. F., Shoelson, S. E., Keutmann, H. and Kahn, C. R., A cascade of tyrosine autophosphorylation in the b-subunit activates the insulin receptor. J. Biol. Chem., 263, 2969-2980 (1988).
78. Withers, D. J., Burks, D. J., Towery, H. H., Altamuro, S. L., Flint, C. L., and White, M. F., Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signalling. Nat. Genet., 23, 32-40 (1999).
79. Withers, D. J., Gutierrez, J. S., Towery, H., Burks, D. J., Ren, J. M., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., Bonner-Weir, S., and White, M. F., Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 391, 900-904 (1998).
80. Wolf, G., Trub, T., Ottinger, E., Groninga, L., Lynch, A., White, M. F., Miyazaki, M., Lee, J., and Shoelson, S. E., The PTB domains of IRS-1 and Shc have distinct but overlapping specificities. J. Biol. Chem., 270, 27407-27410 (1995).
81. Yamauchi, T., Tobe, K., Tamemoto, H., Ueki, K., Kaburagi, Y., Yamamoto-Handa, R., Takahadhi, Y., Yoshizawa, F., Aizawa, S., Akanuma, Y., Sonenberg, N., Yazaki, Y., and Kadowaki, T., Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell Biol., 16, 3074-3084 (1996).
82. Yenush, L. and White, M. F., The IRS-signaling system during insulin and cytokine action. Bio. Essays, 19, 491-500 (1997).
83. Yenush, L., Zanella, C., Uchida, T., Bernal, D., and White, M. F., The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin. Mol. Cell Biol., 18, 6784-6794 (1998).
84. Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z. W., Karin, M., and Shoelson, S. E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science, 293, 1673-1677 (2001).
85. Yuasa, T., Ohno, S., Kehrl, J. H., and Kyriakis, J. M., Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem., 273, 22681-22692 (1998).